Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion - PubMed (original) (raw)
Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion
M Fujimura et al. Brain Res. 1999.
Abstract
Blood-brain barrier (BBB) disruption is thought to play a critical role in the pathophysiology of ischemia/reperfusion. Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes that can degrade all the components of the extracellular matrix when they are activated. Gelatinase A (MMP-2) and gelatinase B (MMP-9) are able to digest the endothelial basal lamina, which plays a major role in maintaining BBB impermeability. The present study examined the expression and activation of gelatinases before and after transient focal cerebral ischemia (FCI) in mice. Adult male CD1 mice were subjected to 60 min FCI and reperfusion. Zymography was performed from 1 to 23 h after reperfusion using the protein extraction method with detergent extraction and affinity-support purification. MMP-9 expression was also examined by both immunohistochemistry and Western blot analysis, and tissue inhibitors to metalloproteinase-1 was measured by reverse zymography. The BBB opening was evaluated by the Evans blue extravasation method. The 88-kDa activated MMP-9 was absent from the control specimens, while it appeared 3 h after transient ischemia by zymography. At this time point, the BBB permeability alteration was detected in the ischemic brain. Both pro-MMP-9 (96 kDa) and pro-MMP-2 (72 kDa) were seen in the control specimens, and were markedly increased after FCI. A significant induction of MMP-9 was confirmed by both immunohistochemistry and Western blot analysis. The early appearance of activated MMP-9, associated with evidence of BBB permeability alteration, suggests that activation of MMP-9 contributes to the early formation of vasogenic edema after transient FCI.
Similar articles
- Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain.
Rosenberg GA, Estrada EY, Dencoff JE. Rosenberg GA, et al. Stroke. 1998 Oct;29(10):2189-95. doi: 10.1161/01.str.29.10.2189. Stroke. 1998. PMID: 9756602 - Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat.
Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. Yang Y, et al. J Cereb Blood Flow Metab. 2007 Apr;27(4):697-709. doi: 10.1038/sj.jcbfm.9600375. Epub 2006 Jul 19. J Cereb Blood Flow Metab. 2007. PMID: 16850029 - Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury.
Gu Y, Zheng G, Xu M, Li Y, Chen X, Zhu W, Tong Y, Chung SK, Liu KJ, Shen J. Gu Y, et al. J Neurochem. 2012 Jan;120(1):147-56. doi: 10.1111/j.1471-4159.2011.07542.x. Epub 2011 Nov 17. J Neurochem. 2012. PMID: 22007835 - Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia.
Rosenberg GA, Yang Y. Rosenberg GA, et al. Neurosurg Focus. 2007 May 15;22(5):E4. doi: 10.3171/foc.2007.22.5.5. Neurosurg Focus. 2007. PMID: 17613235 Review. - The role of matrix metalloproteinase inhibitors in ischemia-reperfusion injury in the liver.
Viappiani S, Sariahmetoglu M, Schulz R. Viappiani S, et al. Curr Pharm Des. 2006;12(23):2923-34. doi: 10.2174/138161206777947560. Curr Pharm Des. 2006. PMID: 16918422 Review.
Cited by
- Blood glucose to predict symptomatic intracranial hemorrhage after endovascular treatment of acute ischemic stroke with large infarct core: a prospective observational study.
Yang Y, Yang L, Shi X, Ni X, Fan S, Xu X, Ma J, Yang S, Wang Z, Zi W, Yang D, Hao Y. Yang Y, et al. Front Neurol. 2024 May 1;15:1367177. doi: 10.3389/fneur.2024.1367177. eCollection 2024. Front Neurol. 2024. PMID: 38751885 Free PMC article. - Dexmedetomidine alleviates blood-brain barrier disruption in rats after cerebral ischemia-reperfusion by suppressing JNK and p38 MAPK signaling.
Zhu C, Wang D, Chang C, Liu A, Zhou J, Yang T, Jiang Y, Li X, Jiang W. Zhu C, et al. Korean J Physiol Pharmacol. 2024 May 1;28(3):239-252. doi: 10.4196/kjpp.2024.28.3.239. Korean J Physiol Pharmacol. 2024. PMID: 38682172 Free PMC article. - Cepharanthine maintains integrity of the blood-brain barrier (BBB) in stroke via the VEGF/VEGFR2/ZO-1 signaling pathway.
Yang Y, Li C, Yang S, Zhang Z, Bai X, Tang H, Huang J. Yang Y, et al. Aging (Albany NY). 2024 Mar 21;16(7):5905-5915. doi: 10.18632/aging.205678. Epub 2024 Mar 21. Aging (Albany NY). 2024. PMID: 38517394 Free PMC article. - NRF2 activation ameliorates blood-brain barrier injury after cerebral ischemic stroke by regulating ferroptosis and inflammation.
Fan W, Chen H, Li M, Fan X, Jiang F, Xu C, Wang Y, Wei W, Song J, Zhong D, Li G. Fan W, et al. Sci Rep. 2024 Mar 4;14(1):5300. doi: 10.1038/s41598-024-53836-0. Sci Rep. 2024. PMID: 38438409 Free PMC article. - Blood-brain barrier disruption imaging in postoperative cerebral hyperperfusion syndrome using DCE-MRI.
Lee K, Yoo RE, Cho WS, Choi SH, Lee SH, Kim KM, Kang HS, Kim JE. Lee K, et al. J Cereb Blood Flow Metab. 2024 Mar;44(3):345-354. doi: 10.1177/0271678X231212173. Epub 2023 Nov 1. J Cereb Blood Flow Metab. 2024. PMID: 37910856 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous